RECHERCHE :   Cancers du sein
Filtrage ? Le champ de filtrage permet de trier les études comportant le mot saisie. La recherche du mot se fait uniquement dans le contenu texte affiché à l'écran.
ETUDE PHASE SITE
CHUV-DO-PART-2016: Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy Treatment
Cancer du sein, du poumon ou métastases pulmonaires
II
CHUV
CMCS110Z2102: A Phase Ib/II, open label, multicenter study of MCS110 in combination with PDR001 in patients with advanced malignancies
Tumeurs malignes avancées: pancréas, sein triple négatif, endomètre, mélanome
II
HUG
IMpassion30/WO39391 : A phase III, multicenter, randomized, open-label study comparing atezolizumab (anti-PDL1 antibody) in combination with adjuvant anthracycline/taxane-based chemotherapy versus chemotherapy alone in patients with operable triple-negative breast cancer
Cancer du sein, triple-négatif
III
CHUV
POSITIVE (IBCSG 48-14-BIG 8-13): A study evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy Sponsor:
Désir de grossesse chez des patientes ayant reçu entre 18 et 30 mois d'hormonothérapie pour un cancer du sein
registre
CHUV, HUG
RACIN, A phase I study of the combination of nivolumab plus ipilimumab associated with low-dose radiation, aspirin, and low-dose cyclophosphamide, followed by nivolumab maintenance, in patients with advanced, TIL-negative solid tumors
Cancer du colon, de la prostate ou du sein récurrent ou métastatique
I
CHUV
SAKK 21/18: Ribociclib-endocrine combination therapy versus chemotherapy as 1st line treatment in patients with visceral metastatic breast cancer. A multicenter, randomized phase III trial
Visceral metastatic breast cancer
III
HUG
SAKK 23/16: Tailored AXIllary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS). A multicenter randomized phase III trial
High risk node-positive breast cancer
III
HUG
SAKK 24/14: Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative EGFR positive breast cancer - A multicenter single arm phase II trial
Cancer du sein avancé triple négatifs, EGFR positif
II
CHUV, HUG
SAKK 96/12: Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks – A Non-Inferiority Phase III Trial
Métastases osseuses dans le cancer de la prostate ou du sein
III
CHUV, HUG
SAKK21/18: Ribociclib-endocrine combination therapy versus chemotherapy as 1st line treatment in patients with visceral metastatic breast cancer. A multicenter, randomized phase III trial.
Cancer du sein, métastatique viscéral
III
CHUV
SAKK 23/16 / IBCSG 57-18 / ABCSG-53 Tailored AXIllary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS). A multicenter randomized phase III trial.
Cancer du sein impliquant les ganglions de l'aisselle
III
CHUV, HUG
CHUV-DO-0012-SolTIL-2018 - Phase Ib Study To Assess The Feasibility And Safety Of Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes In Advanced Solid Tumors
Tumeurs solides
I
CHUV
AMGEN 20140299 - T-VEC Breast-Colorectal: A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects With Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Cancer du sein métastatique triplement négatif ou cancer colorectal avec métastases hépatiques
I
HUG